Dräger Medical JM-103, Руководство по эксплуатации

Страница: 11 / 92

DRAFT 20 June 2005
Jaundice Meter (Model JM-103) User Manual (usr070) Page 2 - 3
SP
ECI
FIC
AT
IO
NS
By calculating the difference in the optical densities, the parts that are
common to the epidermis and dermis are deducted, and as a result, the
difference in the optical densities between the two wavelength regions
can be obtained for the subcutaneous tissue only. Since the optical
density difference shows a linear correlation with the total serum
bilirubin concentration, it is converted to the estimated bilirubin
concentration and is indicated digitally.
The Jaundice Meter (JM-103) device software uses a correlation
coefficient to convert the measurement difference from the dual optical
path to an estimated bilirubin concentration. The calculation formula
used includes the correlation coefficients
α
and
γ.
These coefficients
were determined in pre-clinical testing. The equation used is as follows:
J
sample
=
α
(L-S) +
γ
Where L and S are the long and short optical path measurements.
Use of the Device
Patient Population
The Jaundice Meter (JM-103) is indicated for use in neonatal patients
born >35 weeks gestation who have not undergone transfusion or
phototherapy treatment.